"The basic issue here is that pharmaceutical companies had gotten - TopicsExpress



          

"The basic issue here is that pharmaceutical companies had gotten into the habit of forming "reverse payment" agreements as a way of resolving some patent disputes. In a reverse payment agreement, a company gets paid money to not manufacture a generic alternative to a brand name drug. The FTC filed suit, alleging that this kind of arrangement violates the Federal Trade Commission Act. Both a District court and the 11th Circuit ruled against the FTC, but a Supreme Court coalition of liberals plus Anthony Kennedy reversed the decision today."
Posted on: Mon, 17 Jun 2013 21:26:32 +0000

Trending Topics



Recently Viewed Topics




© 2015